Suppr超能文献

一种新型可扩张冠状动脉钽(斯特雷克)支架:早期实验结果及十二个月随访

A new expandable intracoronary tantalum (Strecker) stent: early experimental results and follow-up to twelve months.

作者信息

Ribeiro P A, Gallo R, Antonius J, Mimish L, Sriram R, Bianchi S, Duran C G

机构信息

Department of Cardiovascular Diseases, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

出版信息

Am Heart J. 1993 Feb;125(2 Pt 1):501-10. doi: 10.1016/0002-8703(93)90032-5.

Abstract

A new radiopaque balloon expandable tantalum stent was tested in the coronary arteries of sheep. A total of 28 stents with a diameter of 2.0 to 3.8 mm were successfully deployed. The stent to coronary artery diameter ratio was 1.1-1.2:1. The animals were heparinized with 100 U/kg of heparin but did not receive antiplatelet drugs. Coronary angiography that was performed 10 minutes after stent implantation showed 100% patency with no side-branch occlusion. Four sheep died within 2 hours of stent implantation, and pathologic studies showed thrombosis of the smaller sized stents: 2 mm (n = 2), 2.8 mm (n = 1), and 3.2 mm (n = 1); three fourths of the sheep had two stents implanted. An oversized stent caused coronary rupture and cardiac tamponade in one other sheep. Follow-up study protocol included coronary angiography before animal sacrifice and pathologic studies within 48 hours (n = 11), 2 weeks (n = 1), 3 months (n = 2), 5 months (n = 1), 10 months (n = 7), and 12 months (n = 1). At 3 to 12 months of follow-up the coronary stent was completely covered with a layer of neointima, and there was no angiographic evidence of coronary stenosis and patent side branches. According to histologic examination, the neointima had nonuniform thickness (20 to 330 microns) and consisted of smooth muscle cells and some collagen. At 7 months of follow-up one of seven stents had angiographic (20%) and pathologic evidence of stenosis, which was secondary to thrombus. The tantalum device is easily deployed technically and notable for its excellent fluoroscopic visibility and flexibility. Thrombosis with a tantalum stent remains a problem, and therefore the larger diameter stents > or = 3.2 mm, antiplatelet drugs, and anticoagulation therapy are indicated for human studies. Implantation of multiple coronary stents increases the risk of stent thrombosis. The long-term, mild neointimal thickness and the patency of the stent and side branches are encouraging.

摘要

一种新型的不透射线的球囊扩张式钽支架在绵羊冠状动脉中进行了测试。总共成功植入了28个直径为2.0至3.8毫米的支架。支架与冠状动脉直径之比为1.1 - 1.2:1。动物用100 U/kg肝素进行肝素化处理,但未接受抗血小板药物治疗。支架植入后10分钟进行的冠状动脉造影显示血管通畅率为100%,且无侧支闭塞。4只绵羊在支架植入后2小时内死亡,病理研究显示较小尺寸的支架出现血栓形成:2毫米(n = 2)、2.8毫米(n = 1)和3.2毫米(n = 1);四分之三的绵羊植入了两个支架。另一只绵羊因过大尺寸的支架导致冠状动脉破裂和心脏压塞。随访研究方案包括在动物处死后进行冠状动脉造影以及在48小时内(n = 11)、2周(n = 1)、3个月(n = 2)、5个月(n = 1)、10个月(n = 7)和12个月(n = 1)进行病理研究。在随访3至12个月时,冠状动脉支架完全被一层新生内膜覆盖,且无冠状动脉狭窄和侧支通畅的血管造影证据。根据组织学检查,新生内膜厚度不均匀(20至330微米),由平滑肌细胞和一些胶原蛋白组成。在随访7个月时,7个支架中有1个出现血管造影(20%)和病理证实的狭窄,这是由血栓引起的。钽装置在技术上易于植入,并且因其出色的荧光透视可见性和柔韧性而值得注意。钽支架的血栓形成仍然是一个问题,因此对于人体研究,建议使用直径大于或等于3.2毫米的较大直径支架、抗血小板药物和抗凝治疗。植入多个冠状动脉支架会增加支架血栓形成的风险。长期来看,新生内膜厚度较薄以及支架和侧支的通畅情况令人鼓舞。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验